{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:12:22Z","timestamp":1780474342930,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2019-110061RB-I00"],"award-info":[{"award-number":["PID2019-110061RB-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID-2021-122766OB-100"],"award-info":[{"award-number":["PID-2021-122766OB-100"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["MCIN\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["MCIN\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PDC2021-121421-I00"],"award-info":[{"award-number":["PDC2021-121421-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PDC2022-133765-I00"],"award-info":[{"award-number":["PDC2022-133765-I00"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["FPU2020"],"award-info":[{"award-number":["FPU2020"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","award":["FPU20\/03326"],"award-info":[{"award-number":["FPU20\/03326"]}],"id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["FPI-2017"],"award-info":[{"award-number":["FPI-2017"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006541","name":"Comunidad de Madrid Consejeria de Sanidad","doi-asserted-by":"publisher","award":["P2022\/BMD-7230"],"award-info":[{"award-number":["P2022\/BMD-7230"]}],"id":[{"id":"10.13039\/501100006541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPI-2020"],"award-info":[{"award-number":["FPI-2020"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PRE2020-091886"],"award-info":[{"award-number":["PRE2020-091886"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["WO 2022\/152800 A1"],"award-info":[{"award-number":["WO 2022\/152800 A1"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA20121"],"award-info":[{"award-number":["CA20121"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.redox.2024.103027","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T15:46:23Z","timestamp":1704296783000},"page":"103027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Specific targeting of the NRF2\/\u03b2-TrCP axis promotes beneficial effects in NASH"],"prefix":"10.1016","volume":"69","author":[{"given":"Raquel","family":"Fern\u00e1ndez-Gin\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Encinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Escoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Carnicero-Senabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Jim\u00e9nez-Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel J.","family":"Garc\u00eda-Yag\u00fce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gueda","family":"Gonz\u00e1lez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Garcia-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Valverde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4039-7140","authenticated-orcid":false,"given":"Antonio","family":"Cuadrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2024.103027_bib1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin. Med."},{"key":"10.1016\/j.redox.2024.103027_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.redox.2024.103027_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cld.2017.08.014","article-title":"Nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis and hepatocellular carcinoma","volume":"22","author":"Massoud","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.redox.2024.103027_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.redox.2024.103027_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s11901-018-0425-7","article-title":"Pathogenesis of NASH: the impact of multiple pathways","volume":"17","author":"Noureddin","year":"2018","journal-title":"Curr. Hepatol. Reports."},{"key":"10.1016\/j.redox.2024.103027_bib6","author":"Peng"},{"key":"10.1016\/j.redox.2024.103027_bib7","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of fibrosis development in nonalcoholic steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2024.103027_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","article-title":"The Nrf2 regulatory network provides an interface between redox and intermediary metabolism","volume":"39","author":"Hayes","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.redox.2024.103027_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2024.103027_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.redox.2024.103027_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2022.06.226","article-title":"Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2","volume":"188","author":"Bathish","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2024.103027_bib12","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1128\/MCB.00677-14","article-title":"Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with","volume":"34","author":"Meakin","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103027_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101638","article-title":"Downregulation of Keap1 confers features of a fasted metabolic state","volume":"23","author":"V Knatko","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.redox.2024.103027_bib14","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jprot.2010.03.018","article-title":"Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver","volume":"73","author":"Kitteringham","year":"2010","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.redox.2024.103027_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jcmgh.2017.11.016","article-title":"Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacologic activation of Nrf2 (NF-E2 p45-related factor 2)","volume":"5","author":"Sharma","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2024.103027_bib16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s42003-021-02100-6","article-title":"Molecular basis for the disruption of Keap1-Nrf2 interaction via Hinge & Latch mechanism","volume":"4","author":"Horie","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.redox.2024.103027_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22526","article-title":"Omaveloxolone and TX63682 are hepatoprotective in the STAM mouse model of nonalcoholic steatohepatitis","author":"Reisman","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.redox.2024.103027_bib18","article-title":"Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice","volume":"5","author":"Seedorf","year":"2023","journal-title":"JHEP Reports Innov. Hepatol."},{"key":"10.1016\/j.redox.2024.103027_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103800","article-title":"Advances in developing noncovalent small molecules targeting Keap1","volume":"28","author":"Barreca","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.redox.2024.103027_bib20","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jhep.2020.01.023","article-title":"NRF2 activates growth factor genes and downstream AKT signaling to induce mouse and human hepatomegaly","volume":"72","author":"He","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2024.103027_bib21","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.26964","article-title":"Activated Nrf2 impairs liver regeneration in mice by activation of genes involved in cell-cycle control and apoptosis","volume":"60","author":"K\u00f6hler","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.redox.2024.103027_bib22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/cancers13010046","article-title":"The KEAP1-NRF2 system as a molecular target of cancer treatment","volume":"13","author":"Taguchi","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.redox.2024.103027_bib23","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40263-021-00842-9","article-title":"The disease-modifying therapies of relapsing-remitting multiple sclerosis and liver injury: a narrative review","volume":"35","author":"Biolato","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.redox.2024.103027_bib24","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/MCB.01204-10","article-title":"SCF\/\u03b2-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a keap1-independent manner","volume":"31","author":"Rada","year":"2011","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103027_bib25","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1128\/MCB.00180-12","article-title":"Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3\/-TrCP Axis","volume":"32","author":"Rada","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2024.103027_bib26","article-title":"An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter \u03b2-TrCP delivers anti-inflammatory responses in mouse liver","volume":"55","author":"Fern\u00e1ndez-Gin\u00e9s","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103027_bib27","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2024.103027_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00795-013-0016-1","article-title":"A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma","volume":"46","author":"Fujii","year":"2013","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.redox.2024.103027_bib29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/ijo.2015.58","article-title":"Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice","volume":"39","author":"Van der Schueren","year":"2015","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.redox.2024.103027_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/srep12466","article-title":"Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis","volume":"5","author":"Saito","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103027_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00535-016-1264-3","article-title":"Nonalcoholic fatty liver disease in Asia: emerging perspectives","volume":"52","author":"Seto","year":"2017","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.redox.2024.103027_bib32","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1074\/jbc.M115.649483","article-title":"Opposite cross-talk by oleate and palmitate on insulin signaling in hepatocytes through macrophage activation","volume":"290","author":"Pardo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2024.103027_bib33","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1248\/bpb.29.588","article-title":"Chronic administration of Satsuma Mandarin fruit (Citrus unshiu MARC.) improves oxidative stress in streptozotocin-induced diabetic rat liver","volume":"29","author":"Sugiura","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.redox.2024.103027_bib34","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1080\/15548627.2016.1208889","article-title":"Transcription factor NFE2L2\/NRF2 is a regulator of macroautophagy genes","volume":"12","author":"Pajares","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.redox.2024.103027_bib35","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1089\/ars.2014.5843","article-title":"The PTEN\/NRF2 axis promotes human carcinogenesis","volume":"21","author":"Rojo","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2024.103027_bib36","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/glia.20947","article-title":"Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease","volume":"8","author":"Rojo","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.redox.2024.103027_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101263","article-title":"Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases","volume":"26","author":"Garc\u00eda-Ruiz","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103027_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.redox.2017.07.006","article-title":"NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology","volume":"13","author":"Rojo","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103027_bib39","author":"Kleiner"},{"key":"10.1016\/j.redox.2024.103027_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.redox.2024.103027_bib41","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.redox.2024.103027_bib42","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2024.103027_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jinorgbio.2012.06.001","article-title":"VO(dmpp)2 normalizes pre-diabetic parameters as assessed by in vivo magnetic resonance imaging and spectroscopy","volume":"115","author":"Metelo","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.redox.2024.103027_bib44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.redox.2024.103027_bib45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/apt.15316","article-title":"Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and\/or obesity","volume":"50","author":"Newsome","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.redox.2024.103027_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677517","article-title":"NASH in lean individuals","volume":"39","author":"Younes","year":"2019","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.redox.2024.103027_bib47","article-title":"Lean non-alcoholic fatty liver disease (Lean-NAFLD) and the development of metabolic syndrome: a retrospective study","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2024.103027_bib48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.redox.2024.103027_bib49","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.redox.2024.103027_bib50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1538\/expanim.17-0112","article-title":"Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis","volume":"67","author":"Akiyama","year":"2018","journal-title":"Exp. Anim."},{"key":"10.1016\/j.redox.2024.103027_bib51","article-title":"Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissue","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2024.103027_bib52","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s11095-013-1138-9","article-title":"Caloric restriction-mediated induction of lipid metabolism gene expression in liver is enhanced by Keap1-knockdown","volume":"30","author":"Kulkarni","year":"2013","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.redox.2024.103027_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/jpet.107.135822","article-title":"NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet","volume":"325","author":"Tanaka","year":"2008","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.redox.2024.103027_bib54","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2009.08.022","article-title":"Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide","volume":"620","author":"Shin","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.redox.2024.103027_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhep.2021.03.005","article-title":"A single cell gene expression atlas of 28 human livers","volume":"75","author":"Brancale","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2024.103027_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/acsptsci.2c00165","article-title":"Cell-permeable PROTAC degraders against KEAP1 efficiently suppress hepatic stellate cell activation through the antioxidant and anti-inflammatory pathway","volume":"6","author":"Wang","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.redox.2024.103027_bib57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.redox.2017.06.010","article-title":"Transcription factor NRF2 controls the fate of neural stem cells in the subgranular zone of the hippocampus","volume":"13","author":"Robledinos-Ant\u00f3n","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2024.103027_bib58","author":"Sander"},{"key":"10.1016\/j.redox.2024.103027_bib59","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","article-title":"AdmetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties","volume":"35","author":"Yang","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.redox.2024.103027_bib60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2014.02.021","article-title":"Monitoring fibrogenic progression in the liver","volume":"433","author":"Gressner","year":"2014","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.redox.2024.103027_bib61","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1055\/s-0036-1586228","article-title":"The role of plasminogen activator inhibitor type-1 in fibrosis","volume":"43","author":"Flevaris","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.redox.2024.103027_bib62","doi-asserted-by":"crossref","first-page":"W175","DOI":"10.1093\/nar\/gkac199","article-title":"ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data","volume":"50","author":"Zou","year":"2022","journal-title":"Nucleic Acids Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172400003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221323172400003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:02:32Z","timestamp":1778853752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221323172400003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":62,"alternative-id":["S221323172400003X"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2024.103027","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific targeting of the NRF2\/\u03b2-TrCP axis promotes beneficial effects in NASH","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2024.103027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103027"}}